The safety of formoterol among patients with asthma using inhaled corticosteroids. Systematic review and meta-analysis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 118, Issue 11, 2008, Pages 627-635

  Jaeschke, Roman ^a,b,f   O'Byrne, Paul M ^a   Nair, Parameswaran ^a   Mejza, Filip ^b,c   Leśniak, Wiktoria ^b,c   Brozek, Jan ^b,c,d   Thabane, Lehana ^a,e   Cheng, Ji ^e   Bała, Małgorzata ^b,c   Schünemann, Holger J ^a,d,e   Sears, Malcolm R ^a   Guyatt, Gordon ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Polish Institute of Evidence Based Medicine   (Poland)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e MCMASTER UNIVERSITY   (Canada)

^f Fontbonne Building ^*  (Canada)

Author keywords

Asthma; Formoterol; Hospitalizations; Inhaled corticosteroids; Mortality; Safety

Indexed keywords

CORTICOSTEROID; FORMOTEROL; FORMOTEROL FUMARATE;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG SAFETY; HOSPITALIZATION; HUMAN; INTUBATION; META ANALYSIS; MORBIDITY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 57149110041     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.508     Document Type: Article

References (17)

1. Castle W, Fuller R, Hall J, et al. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchoditetor treatment. BMJ. 1993; 306: 1034-1037.
2. Nelson HS, Weiss ST, Bleecker ER, et al; SMART Study Group. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006; 129: 15-26.
3. Salpeter SR, Buckley NS, Ormiston TM, et al. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann Intern Med. 2006; 144: 904-912.
4. Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews 2008; 3: CD006363.
5. Martinez FD. Safety of long-acting β-agonists - an urgent need to clear the air. N Eng J Med. 2005; 353: 2637-2639.
6. http://www.ginasthma.com/(date of last access 12/13/2007).
7. http://www.nhlbi.nih.gov/guidelines/asthma/(date of last access 12/13/2007).
8. Jaeschke R, O'Byrne PM, Mejza F, et al. The safety of long acting β-agonists among patients with asthma using inhaled corticosteroids. Systematic review and meta-analysis. Am J Respir Grit Care Med. Articles in Press. Published on September 5, 2008 as doi:10.1164/rccm.200804-4940C.
9. Bateman E, Nelson H, Bousquet J, et al. Meta-analysis: Effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events. Ann Intern Med. 2008; 149: 33-42.
10. Jaeschke R, Mejza F, Lesniak W, et al. The safety of formoterol among patients with asthma using inhaled corticosteroids. Abstract Book, ATS 2007: A57.
11. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986; 7: 177-188
12. Mitchell C, Jenkins C, Scicchitano R, et al. Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to severe asthma. Pulm Pharmacol Ther. 2003; 16: 299-306.
13. Fitz Gerald JM, Chapman KR, Della Cioppa G, et al. Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. J All Clin Immunol. 1999; 103: 427-435.
14. McIvor RA, Pizzichini E, Turner MO, et al. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med. 1998; 158: 924-930.
15. Emst P, McIvor A, Oucharme FM, et al: Canadian Asthma Guideline Group. Safety and effectiveness of long-acting inhaled β-agonist bronchodilators when taken with inhaled corticosteroids. Ann Intern Med. 2006; 145: 692-694.
16. 2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst Rev. 2005: CD005535.
17. 2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Cochrane Database Syst Rev. 2005: CD006533.